Biotechnology: The Patenting of DNA Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology: The Patenting of DNA

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote ()	6/26/1999 7:36:00 PM
From: Pseudo Biologist	Read Replies (1) of 37

The post below (originally made to the SIBI board) triggered and interesting discussion on patents of drug discovery tools and what may be fair or not. Regardless of the particulars of the PFE/SIBI dispute, and of the motivation of PFE, I think this "fight" raises a number of far reaching issues, including "royalty stacking," how valuable "tools" (which may include DNA when used as part of a broader drug discovery program) really are, and thus how much fees, and royalties their inventors may deserve, etc, etc. The outcome of disputes such as these may have implications to other "tool making" companies in biotech. These companies, at some point, were even thought to have discovered the "magic" formula of taking out a lot of the risk in drug discovery and development, without giving up too much of the upside. Message 10262896 Flame away, PB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next